Revenue | ₹5.22Cr |
Net Profits | ₹0.15Cr |
Net Profit Margins | 2.87% |
Beryl Drugs Ltd’s revenue jumped 62.62% since last year same period to ₹5.22Cr in the Q4 2024-2025. On a quarterly growth basis, Beryl Drugs Ltd has generated -3.33% fall in its revenue since last 3-months.
Beryl Drugs Ltd’s net profit jumped 142.86% since last year same period to ₹0.15Cr in the Q4 2024-2025. On a quarterly growth basis, Beryl Drugs Ltd has generated 200% jump in its net profits since last 3-months.
Beryl Drugs Ltd’s net profit margin jumped 126.35% since last year same period to 2.87% in the Q4 2024-2025. On a quarterly growth basis, Beryl Drugs Ltd has generated 210.34% jumped in its net profit margins since last 3-months.
The revenue for Beryl Drugs Ltd in the Q4 results 2024 was ₹5.22Cr.
The net profit for Beryl Drugs Ltd in the Q4 results 2024 was ₹0.15Cr.
The net profit margin for Beryl Drugs Ltd in the Q4 results 2024 was 2.87%.
The revenue for Beryl Drugs Ltd in the Q4 results 2023 was ₹3.21Cr.
The net profit for Beryl Drugs Ltd in the Q4 results 2023 was ₹0.35Cr.
The net profit margin for Beryl Drugs Ltd in the Q4 results 2023 was -10.90%.